Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study. - Winkler,K.; Konrad,T.; Fullert,S.; Friedrich,I.; Destani,R.; Baumstark,M.W.; Krebs,K.; Wieland,H.; März,W. (Diab Care, 2003)